Gallery ORLADEYO (oral treatment) is recommended for reimbursement in Quebec daphnecanada2023-09-18T14:57:16-06:00 ORLADEYO (oral treatment) is recommended for reimbursement in Quebecdaphnecanada2023-09-18T14:57:16-06:00
Gallery TAKHZYRO available through Veterans Affairs Canada daphnecanada2023-06-28T11:50:13-06:00 TAKHZYRO available through Veterans Affairs Canadadaphnecanada2023-06-28T11:50:13-06:00
Gallery TAKHZYRO available in PEI daphnecanada2023-06-28T11:27:53-06:00 TAKHZYRO available in PEIdaphnecanada2023-06-28T11:27:53-06:00
Gallery Improved access to affordable and effective drugs for rare diseases in Canada daphnecanada2023-03-23T14:01:00-06:00 Improved access to affordable and effective drugs for rare diseases in Canadadaphnecanada2023-03-23T14:01:00-06:00
Gallery CADTH Recommends Reimbursement for ORLADEYO daphnecanada2023-03-23T12:25:03-06:00 CADTH Recommends Reimbursement for ORLADEYOdaphnecanada2023-03-23T12:25:03-06:00
Gallery Rare Disease Day Breakfast with CORD daphnecanada2023-03-08T15:07:22-06:00 Rare Disease Day Breakfast with CORDdaphnecanada2023-03-08T15:07:22-06:00
Gallery HAEC Board member featured in Canada’s Rare Voices 2023 daphnecanada2023-02-16T14:22:37-06:00 HAEC Board member featured in Canada’s Rare Voices 2023daphnecanada2023-02-16T14:22:37-06:00
Gallery Updates to our Board of Directors daphnecanada2023-02-24T12:09:59-06:00 Updates to our Board of Directorsdaphnecanada2023-02-24T12:09:59-06:00
Gallery 2022 HAEi Global Leadership Workshop daphnecanada2022-10-18T11:24:04-06:00 2022 HAEi Global Leadership Workshopdaphnecanada2022-10-18T11:24:04-06:00
Gallery CBS Announces Results of the RFP for PPRP daphnecanada2022-09-29T09:22:27-06:00 CBS Announces Results of the RFP for PPRPdaphnecanada2022-09-29T09:22:27-06:00
